Estrogen hormone therapy and postmenopausal osteoporosis: does it really take two to tango?

被引：1
|
作者：
Silva, Barbara Campolina [1 ]
Rodrigues, Marcio Alexandre Hipolito [2 ,3 ]
机构：
[1] Santa Casa Hosp, Endocrinol Unit, Belo Horizonte, Brazil
[2] Univ Fed Minas Gerais, Sch Med, Obstet & Gynecol Dept, Belo Horizonte, Brazil
[3] Hosp Cochin, Endocrine Gynecol Unit, Paris, France
来源：
WOMEN & HEALTH | 2023年 / 63卷 / 10期
关键词：
BONE-MINERAL DENSITY; PLUS PROGESTIN; HEALTH; RISK; MANAGEMENT; FRACTURE; WOMEN;
D O I：
10.1080/03630242.2023.2278211
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：770 / 773
页数：4
相关论文
共 50 条
  • [31] Long-term Effects on Cognitive Trajectories of Postmenopausal Hormone Therapy in Two Age Groups
    Espeland, Mark A.
    Rapp, Stephen R.
    Manson, JoAnn E.
    Goveas, Joseph S.
    Shumaker, Sally A.
    Hayden, Kathleen M.
    Weitlauf, Julie C.
    Gaussoin, Sarah A.
    Baker, Laura D.
    Padula, Claudia B.
    Hou, Lifang
    Resnick, Susan M.
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2017, 72 (06): : 838 - 845
  • [32] Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older women: association with estrogen receptor-α genotypes
    Sai, Adarsh J.
    Gallagher, J. Christopher
    Fang, Xiang
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2011, 18 (10): : 1101 - 1112
  • [33] Comparison of Two Different Types of Hormone Therapy Effects on Haemostatic Parameters in Early Postmenopausal Women
    Tasic, Lidija
    Dunjic, Radica
    Vasiljevic, Mladenko
    Dikic, Svetlana
    Jurisic, Aleksandar
    Tasic, Dijana
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2011, 139 (1-2) : 52 - 57
  • [34] Efficacy of Recombinant Human Parathyroid Hormone 1-34 and Vitamin K2 Combination Therapy in Postmenopausal Osteoporosis
    Zhang, Zhuo
    Xia, Kun
    Gong, Wentao
    Mai, Ruopeng
    Lu, Zhaogang
    HORMONE AND METABOLIC RESEARCH, 2025, 57 (01) : 33 - 38
  • [35] Invited Commentary: Hormone Therapy Risks and Benefits-The Women's Health Initiative Findings and the Postmenopausal Estrogen Timing Hypothesis
    Banks, Emily
    Canfell, Karen
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 170 (01) : 24 - 28
  • [36] Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study
    Barrett-Connor, E
    Wehren, LE
    Siris, ES
    Miller, P
    Chen, YT
    Abbott, TA
    Berger, ML
    Santora, AC
    Sherwood, LM
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2003, 10 (05): : 412 - 419
  • [37] A comparison of two different dosages of conjugated equine estrogen in continuous combined hormone replacement therapy with progestin
    Xing, SM
    Wu, YY
    Liu, JL
    Xu, RL
    Zhang, ZL
    CHINESE MEDICAL JOURNAL, 2003, 116 (04) : 584 - 587
  • [38] Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis
    Dane, Cem
    Dane, Banu
    Cetin, Ahmet
    Erginbas, Murat
    GYNECOLOGICAL ENDOCRINOLOGY, 2007, 23 (07) : 398 - 403
  • [39] Adjuvant endocrine therapy in postmenopausal breast cancer patients: Does hormone receptor status influence decision-making?
    Puglisi, Fabio
    Minisini, Alessandro Marco
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 77 (02) : 87 - 99
  • [40] Coronary Heart Disease in Postmenopausal Recipients of Estrogen Plus Progestin Therapy: Does the Increased Risk Ever Disappear? A Randomized Trial
    Toh, Sengwee
    Hernandez-Diaz, Sonia
    Logan, Roger
    Rossouw, Jacques E.
    Hernan, Miguel A.
    ANNALS OF INTERNAL MEDICINE, 2010, 152 (04) : 211 - U30
12345